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Restoration of Visual Function by Expression of a Light-Gated
Mammalian Ion Channel in Retinal Ganglion Cells or ON-Bipolar Cells
Abstract
Most inherited forms of blindness are caused by mutations that lead to photoreceptor cell death but spare
second- and third-order retinal neurons. Expression of the light-gated excitatory mammalian ion channel
light-gated ionotropic glutamate receptor (LiGluR) in retinal ganglion cells (RGCs) of the retina
degeneration (rd1) mouse model of blindness was previously shown to restore some visual functions when
stimulated by UV light. Here, we report restored retinal function in visible light in rodent and canine models
of blindness through the use of a second-generation photoswitch for LiGluR, maleimide-azobenzene-
glutamate 0 with peak efficiency at 460 nm (MAG0460). In the blind rd1 mouse, multielectrode array
recordings of retinal explants revealed robust and uniform light-evoked firing when LiGluR-MAG0460 was
targeted to RGCs and robust but diverse activity patterns in RGCs when LiGluR-MAG0460 was targeted to
ON-bipolar cells (ON-BCs). LiGluR-MAG0460 in either RGCs or ON-BCs of the rd1 mouse reinstated
innate light-avoidance behavior and enabled mice to distinguish between different temporal patterns of light
in an associative learning task. In the rod-cone dystrophy dog model of blindness, LiGluR-MAG0460 in RGCs
restored robust light responses to retinal explants and intravitreal delivery of LiGluR and MAG0460 was well
tolerated in vivo. The results in both large and small animal models of photoreceptor degeneration provide a
path to clinical translation.
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Most inherited forms of blindness are caused by mutations that
lead to photoreceptor cell death but spare second- and third-order
retinal neurons. Expression of the light-gated excitatory mamma-
lian ion channel light-gated ionotropic glutamate receptor (LiGluR)
in retinal ganglion cells (RGCs) of the retina degeneration (rd1)
mouse model of blindness was previously shown to restore some
visual functions when stimulated by UV light. Here, we report re-
stored retinal function in visible light in rodent and canine models
of blindness through the use of a second-generation photoswitch
for LiGluR, maleimide-azobenzene-glutamate 0 with peak efficiency
at 460 nm (MAG0460). In the blind rd1 mouse, multielectrode array
recordings of retinal explants revealed robust and uniform light-
evoked firing when LiGluR-MAG0460 was targeted to RGCs and ro-
bust but diverse activity patterns in RGCs when LiGluR-MAG0460
was targeted to ON-bipolar cells (ON-BCs). LiGluR-MAG0460 in either
RGCs or ON-BCs of the rd1 mouse reinstated innate light-avoidance
behavior and enabled mice to distinguish between different tem-
poral patterns of light in an associative learning task. In the rod-
cone dystrophy dog model of blindness, LiGluR-MAG0460 in RGCs
restored robust light responses to retinal explants and intravitreal
delivery of LiGluR and MAG0460 was well tolerated in vivo. The
results in both large and small animal models of photoreceptor
degeneration provide a path to clinical translation.
retinal gene therapy | visual prosthetics | retinitis pigmentosa |
optogenetic pharmacology | azobenzene photoswitches
Inherited retinal degenerative diseases affect 1 in 3,000 humansworldwide (1). Retinitis pigmentosa (RP) describes a family of
over 50 different gene mutations that cause progressive loss of
rod photoreceptors (1, 2). Rod loss is followed by degeneration
of cone photoreceptors, ultimately leading to complete blindness
in many patients (3). Despite the complete loss of photoreceptors
in the outer nuclear layer, many interneurons of the inner retina
survive in a functional state for long periods, providing an op-
portunity for treatment (4, 5).
Direct electrical stimulation of the surviving inner retina has
proven to be successful in restoring useful vision (6–8). One
approach employs surgically implanted photovoltaic or electrode
arrays to stimulate retinal ganglion cells (RGCs) (8) or bipolar
cells (BCs) (6, 7) directly in the inner nuclear layer (INL) of the
degenerated retina, and promising results in clinical trials have
led to US Food and Drug Administration approval for the Argus
II device (Second Sight Medical Products, Inc.) (8). The elec-
trical implants demonstrate that inner retinal neurons in blind
patients can respond to appropriate stimulation and lead to
a useful visual percept allowing simple navigation and object
recognition. These electronic designs are under continual de-
velopment to increase the resolution, improve the surgical im-
plantation procedures, and increase the sophistication of their
signal-encoding algorithms (9).
Microbial opsins, like channelrhodopsin and halorhodopsin,
have been successfully tested as visual prosthetics in animal
models of human blindness (10–15). Genetically encoded light-
gated proteins can be exogenously expressed in retinal cells using
viral or nonviral gene delivery vehicles, imparting a light-sensi-
tive function to cone photoreceptors that have become in-
sensitive to light from loss of their outer segments (14), but also
to ON-BCs (12, 13), as well as RGCs (10, 15, 16), leading to
rescue of basic aspects of visual function in mice. Microbial
opsins are appealing for this application due to the bioavailability
of the light-sensitive ligand retinal. However, there are potential
drawbacks to this approach. Xenotransplantation is generally
concerning, because it might lead to immune responses and in-
flammation potentially spreading to the brain via the optic nerve.
Significance
We restored visual function to animal models of human blind-
ness using a chemical compound that photosensitizes a mam-
malian ion channel. Virus-mediated expression of this light
sensor in surviving retinal cells of blind mice restored light re-
sponses in vitro, reanimated innate light avoidance, and en-
abled learned visually guided behavior. The treatment also
restored light responses to the retina of blind dogs. Patients
that might benefit from this treatment would need to have
intact ganglion cell and nerve fiber layers. In general, these are
patients diagnosed with retinitis pigmentosa and some forms
of Leber congenital amaurosis. Patients diagnosed with other
types of blindness, for example, age-related macular de-
generation or diabetic retinopathy, would not be candidates
for this treatment.
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Additionally, once expressed, it is impossible to silence the sys-
tem in case of adverse reactions in patients.
One promising alternative to microbial opsins is an opto-
pharmacological strategy that uses synthetic azobenzene-based
photoswitches to endow light sensitivity either to native ion chan-
nels of neurons (17, 18) or to engineered mammalian receptors
and channels that, like the microbial opsins, allow for genetic
targeting to specific cells (19–22). We previously showed that an
engineered light-gated ionotropic glutamate receptor (LiGluR)
restores light responses to blind retina degeneration (rd1) mice
(23). The gene encoding for LiGluR was delivered to RGCs by
intravitreal injection of adeno-associated virus (AAV), and the
photoswitchable tethered ligand maleimide-azobenzene-glutamate
(MAG) was delivered in a subsequent intravitreal injection (23).
LiGluR contains a single Cys substitution in the kainate re-
ceptor,GluK2(439)C, which serves as an anchoring site for MAG
close to the ligand binding site. Upon illumination at 380 nm in the
near-UV range, the azobenzene linker in MAG photoisomerizes
from trans to cis, shortening the molecule and allowing the gluta-
mate to bind into the ligand binding pocket to activate and open
the channel.
The first-generation MAG photoswitch suffered from two
major limitations for vision restoration: (i) The UV light needed
for activation is absorbed by the human lens and can damage the
retina, and (ii) MAG is bistable, requiring a second pulse of light
at a longer wavelength for deactivation. We recently developed
a second-generation photoswitch, maleimide-azobenzene-glutamate
0 with peak efficiency at 460 nm (MAG0460), to overcome
these problems (24). MAG0460 is activated by white light and
spontaneously turns off in the dark. In the present study, we
compare retinal light responses and both innate and learned vi-
sually guided behaviors in the rd1 mouse model of retina de-
generation when LiGluR-MAG0460 is targeted to either RGCs or
ON-BCs. We find that both cell types support robust light-induced
retinal activity and visually guided behavior. To demonstrate ef-
ficacy in a larger animal model, we targeted LiGluR-MAG0460 to
RGCs in a canine model of human blindness and restored light-
activated retinal responses in vitro. Because LiGluR-MAG0460 is
functional in both the mouse and dog, it is an attractive candidate
for a genetically encoded retinal prosthetic for the blind.
Results
Restoration of Light Response to the Retina of the rd1 Mouse by
LiGluR in RGCs or ON-BCs. Our first-generation MAG photo-
switch for LiGluR had limited utility for vision restoration be-
cause it required 380-nm UV light stimulation for activation and
a second pulse of light at a longer wavelength for deactivation
(19, 25). We therefore turned to a recently developed second-
generation compound, MAG0460, which is activated by blue or
white light and spontaneously turns off in the dark (Fig. 1).
Expression and labeling in human embryonic kidney (HEK)
cells yielded robust LiGluR-MAG0460 photocurrents that were
stable and reversible over hundreds of switching cycles (24). Im-
portantly, LiGluR-MAG0460 photocurrents scaled with light
intensity, yielding a sigmoid intensity-response curve spanning
three orders of magnitude (Fig. 1D, Fig. S1, and SI Text). In addition,
LiGluR responded dynamically to moderate frequencies of intensity
modulation (Fig. S1 C and D).
We tested the expression and function of LiGluR-MAG0460 in
the retina of the rd1 mouse, a small animal model of human
blinding disease. The rd1 mouse has a null mutation in the phos-
phodiesterase type 6 (PDE6)-beta subunit causing complete loss
of rod and cone photoreceptors by postnatal day 90 (p90) (26).
This phenotype is comparable to patients in the early stages of
retinal degeneration who may still have a functioning network of
all retinal cell types except for the photoreceptors. At later stages,
however, only the RGCs may survive (4, 27). To address both early
and late stages of the disease, we examined the effect of targeting
LiGluR to either the RGCs or ON-BCs (Fig. 2 C and E).
Good restriction of LiGluR expression in RGCs was achieved
using an AAV vector combining the human synapsin promoter
(hsyn-1) and the AAV 2/2 capsid as previously described (23).
The gene expression cassette (Fig. 2A) in a volume of 2 μL
containing 109–1010 viral genomes was injected into the vitreous
of rd1mice. Expression was visualized >4 wk after injection using
an antibody against the GluK2 subunit from which LiGluR is
composed (19). Intravitreal injection of the vector resulted in
expression in the RGC layer (Fig. 2 D and G and Fig. S2A). Due
to the limited retinal penetration of the AAV2/2 serotype (15)
and the lack of syn-1 expression in choline acetyltransferase-
positive amacrine cells (28), these transduced cells are likely to
be predominantly RGCs. LiGluR expression was panretinal and
localized to soma and dendrites of both ON- and OFF-RGCs, as
seen by stratification of the dendritic terminals in both on- and off-
sublayers of the inner plexiform layer (IPL) (Fig. 2G and Fig. S2A).
Targeting ON-BCs required the use of an AAV capsid
with deeper tissue penetration and an ON-BC–specific promoter.
To achieve deeper penetration, we turned to the tyrosine mutant
AAV2/2 capsids (29), which are protected from proteasome
degradation, leading to better transduction in the inner retina. We
restricted LiGluR expression to ON-BCs with a four-copy con-
catemer of a minimal version of the cell-specific metabotropic
glutamate receptor 6 promoter (mGluR6) promoter (4xgrm6) (12,
30). This gene expression cassette (Fig. 2B) was packaged into
AAV2/2(4YF) (29) and injected subretinally in rd1 mice (1–2 mo
old), creating a bleb covering ∼25% of the retinal surface (Fig.
S2B). Subretinal injections were used instead of intravitreal
injections because this route enabled us to deposit the AAV closer
to the ON-BC target cells. Expression was confirmed >6 wk after
virus injection by staining with the anti-GluK2 antibody, and it was
predominantly found in ON-BCs, as seen by stratification of the
Fig. 1. LiGluR-MAG0460 expressed in HEK cells is activated by visible light,
relaxes in the dark, and detects changes in light intensity. (A) Schematic of
the LiGluR. After tethering a photoswitchable ligand, L-MAG0460, the channel
is activated by light and closes in darkness. (B) Structural formula of the
second-generation L-MAG0460 photoswitch (24). hv, frequency × Planck con-
stant; kBT, Boltzmann constant × temperature. (C) HEK cell recordings in
voltage-clamp configuration at −75 mV. (Top) LiGluR conjugated with
MAG0460 is activated by blue light and relaxes spontaneously in the dark.
(Bottom) For comparison, LiGluR gating with the first-generation MAG0
photoswitch, which is bistable (380 nm of light opens the channel, 500 nm of
light closes it), is shown. (D) Dynamic range of LiGluR-MAG0460 with respect to
light intensity. LiGluR-MAG0460 responds over a wide range of intensities (0.5–
500mW/cm2 or 1.1 × 1015 photons per cm−2·s−1 to 1.1 × 1018 photons per cm−2·s−1)
with a sigmoid intensity-response profile (normalized steady-state currents,
mean ± SD, n = 3 experiments). rel., relative. Details are provided in Fig. S1
and SI Text.














axon terminals in the on-sublayer of the IPL in the area under the
bleb (Fig. 2 F and H and Fig. S2B).
Retinal explants from rd1 mice (>3 mo old) were mounted on
a 60-channel multielectrode array (MEA) to test light-evoked
activity. Aside from a small fraction of sluggish, intrinsically
photosensitive RGCs, retinas from untreated rd1 mice showed
no blue light-induced firing (Fig. S2E), consistent with the ab-
sence of rods and cones. Incubation of untreated rd1 retina with
100 μMMAG0460 followed by washout left them unresponsive to
blue light (Fig. S2F). In contrast, rd1 retinas expressing LiGluR
in RGCs, which were insensitive to blue light (Fig. 2I), showed
strong light-induced firing following exposure to MAG0460 (Fig.
2 K and M). Similarly, rd1 retinas expressing LiGluR in ON-BCs
were insensitive to blue light (Fig. 2J) until they were exposed to
MAG0460 (Fig. 2 L and N). Stimulation with broad-spectrum
(white) light triggered similar responses (Fig. S2G), as demon-
strated previously in HEK cells (24). Both in RGCs and ON-BCs,
LiGluR-MAG0460 was able to drive light responses at moderate
intensities (0.3 mW/cm2 or 7.1 × 1014 photons per cm−2·s−1 for
RGCs and 0.2 mW/cm2 or 4.7 × 1014 photons per cm−2·s−1 for
ON-BCs, respectively, Fig. 3 A and B), representing an ∼10-fold
improvement in sensitivity compared with the published values
for the first-generation MAG photoswitch (23).
Kinetics and Frequency Detection Supported by Light-Sensitive RGCs
and ON-BCs. Ideally, a visual prosthetic should have low variability,
elicit RGC firing similar to wild-type (wt) conditions, and show
fast dynamics to restore natural vision after loss of photoreceptor
cells (31–33). LiGluR-MAG0460 expressed in ON-BC and RGC
showed low cell-to-cell variability (Fig. S3) similar to wt retinas.
The firing rate above baseline (Fig. S3A) and the type of response
(Fig. S3B) to a full-field flash of light was comparable. This was
also true for retina-to-retina variability (Fig. S4 and Table S1)
measured in vitro. We found that light pulses as short as 35 ms in
duration were sufficient to trigger robust RGC firing when
LiGluR-MAG0460 was expressed in either RGCs or ON-BCs (Fig.
3 C and D). In both cases, the responses reached a peak firing rate
similar to the peak firing rate observed with much longer pulses of
light (compare Fig. 2 K and L with Fig. 3 C and D).
The responses had a short delay following light onset and ter-
minated rapidly from peak response to baseline as shown by the
decay constant tau (τ) (τoff = 51.96 ms, SEM = 3.48 with LiGluR-
MAG0460 in RGCs; τoff = 62.87 ms, SEM = 5.26 with LiGluR-
MAG0460 in ON-BCs), with values from steady state to baseline
[LiGluR-MAG0460 in RGCs: response inactivation time (ΔToff) =
40 ms (Fig. S5C), LiGluR-MAG0460 in ON-BCs: ΔToff = 80 ms
(Fig. S5D)]. The similarity between RGC-driven (Fig. 3C and
Fig. S5C) and ON-BC–driven (Fig. 3D and Fig. S5D) termina-
tion suggests that the decay kinetics are mostly governed by li-
gand inactivation from the cis to trans state, and the speed (Fig. 3
C and D) suggests that these systems should enable retinal out-
put to follow high-frequency modulation of light intensity. We
tested this hypothesis by measuring RGC firing in response to
trains of short light pulses given at either 4 Hz (50-ms flashes at
a 200-ms interstimulus interval) or 10 Hz (50-ms flash with a 50-
ms interstimulus interval) with LiGluR-MAG0460 in RGCs (Fig.
3 E andG) or in ON-BCs (Fig. 3 F andH). In both cases, at 4 Hz,
the individual RGCs responded to every flash of light. With in-
creasing frequency, the light-induced firing rate decreased (Fig.
S5B) and individual cells stochastically missed some responses
(Fig. S5A). At the population level, however, rd1 retinas with
LiGluR-MAG0460 in RGCs and ON-BCs reliably followed 4-Hz
(Fig. 3 E and F) and 10-Hz stimulation frequencies (Fig. 3 G
and H). LiGluR-MAG0460 elicited graded changes in the RGC
firing rate in response to graded changes in light intensity (Fig.
S5G) similar to what we saw in HEK cells (Fig. S1C).
Fig. 2. LiGluR expression downstream in RGCs and upstream in ON-BCs
restores light responses in the rd1 mouse retina in vitro (light intensity for
all recordings: 27.7 mW/cm2 or 6.3 × 1016 photons per cm−2·s−1). (A and B)
Viral DNA expression cassette. LiGluR is flanked by inverted terminal re-
peat (ITR) domains and stabilized by a polyadenylation signal sequence
(polyA) and a woodchuck hepatitis posttranscriptional regulatory element
(WPRE). ONL, outer nuclear layer. LiGluR expression is driven by hsyn-1 (A)
or 4xgrm6 (B). (C and E ) Schematic of a degenerated rd1mouse retina with
targeted cells highlighted in green. Confocal images of LiGluR expression
in RGCs of rd1 mouse retina >4 wk after intravitreal injection of AAV2/2-
hSyn-LiGLuR (2-μL volume equal to 5 × 1011 viral genomes) (D and G) or
ON-BCs of rd1 mouse retina >6 wk after subretinal injection of AAV2/2-
(4YF)-4xgrm6-LiGLuR (2-μL volume equal to 5 × 1011 viral genomes) (F and
H). Retinas were stained with an anti-GluK2 antibody (green), and nuclei
were stained with DAPI (blue). (Scale bars: 10 μm.) The IPL is shown with
indication of on- and off-sublayers. MEA recordings from rd1 mouse reti-
nas expressing LiGluR in RGCs (I and K ) or ON-BCs (J and L) in the absence
(I and J) or presence (K and L) of MAG0460. (Top) Light stimulation pro-
tocol: 5× 3 s of blue light and 8 s dark. (Middle) Raster plot with spikes for
all light-sensitive RGCs (I and K, n = 130 cells; J and L, n = 46 cells). (Bottom)
Peristimulus time histogram (PSTH) with 250-ms bins. Comparison of the
average firing rates (500-ms bins) in the light vs. dark for rd1 retinas
expressing LiGLuR in RGCs (M) and ON-BCs (N) in the absence (gray) (M: n = 6
retinas, 478 cells; N: n = 4 retinas, 416 cells) and presence (green) (M, n = 5
retinas, 303 cells; N, n = 4 retinas, 332 cells) of MAG0460 and population mean
(black and blue, respectively).
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Differences Between Light-Induced RGC Firing with LiGluR in RGCs vs.
ON-BCs. More than 20 different subtypes of RGCs have been
classified in the mouse retina to date based on physiology and
morphology, including dendritic stratification and input path-
ways (34, 35). Some of the synaptic connections in the INL are
maintained in early stages of degeneration (5, 36). Engaging
those synaptic connections through LiGluR expression in ON-
BCs may lead to diverse light responses in the downstream
RGCs, indicating that aspects of RGC identity might be retained
or restored. In contrast, bypassing these synaptic connections by
LiGluR expression in RGCs themselves should lead to uniform
responses across all LiGluR-RGCs regardless of their original
identity (e.g., ON vs. OFF, transient vs. sustained).
To explore our hypothesis in vitro using the MEA, we exam-
ined single-unit RGC responses to 1-s flashes of light for four
different conditions: wt (Fig. 4A), rd1 LiGluR-MAG0460 in ei-
ther RGCs (Fig. 4B) or ON-BCs (Fig. 4C), and rd10 LiGluR-
MAG0460 in ON-BCs (Fig. 4D). Nonpatterned light was used as
a stimulus to allow comparisons to be made without concern for
variability of LiGluR expression levels and density (compare Fig.
2 D and F and Fig. S2 A and B). Peristimulus time histograms
(PSTH) were plotted for each recording (Fig. 4 E–H). In rd1
mice, RGCs with LiGluR-MAG0460 showed uniform responses,
with similar onset delays and decay rates (Fig. 4 B and F). The
photoswitching index (PI; normalized difference in firing rates in
the light vs. dark) was positive for every cell (Fig. 4F) as expected
for its direct excitation by LiGluR-MAG0460. In contrast, rd1
RGCs that received synaptic input upstream from ON-BCs with
LiGluR-MAG0460 showed more diverse responses (Fig. 4C). Some
cells were excited by light, and others were inhibited (Fig. 4 C and
G). The onset, offset, and duration of the light response also varied
among cells (Fig. 4C) similar to wt retina (Fig. 4 A and E).
The diversity of responses seen in single units prompted us to
ask if this effect could be seen more globally at the level of the
retina, taking into account all of the cells from one recording.
Rather than averaging across cells, and thus masking cell-to-cell
variation, we wanted to analyze all responses systematically from
each cell individually to understand the relationship between the
RGC firing patterns generated by LiGluR-MAG0460 installed
in the RGCs themselves or in the ON-BCs. To this end, we
correlated the PSTH (the firing rate of a given cell over time) of
all cells with one another and constructed a correlation matrix in
which each data point represents the correlation value (r).
Responses during the 1-s light flash and responses 100 ms before
Fig. 3. LiGluR-MAG0460 in RGCs and ON-BCs of rd1mouse retina drives light
responses with similar characteristics (other than for A and B, light intensity
for all recordings is 24.7 mW/cm2 or 5.6 × 1016 photons per cm−2·s−1). (A–H)
MEA recordings of rd1 mouse retinas treated with LiGluR-MAG0460 in RGCs
(Left) or ON-BCs (Right). .(A and B) Dynamic range with 3-s stimulation
(A: n = 4 retinas, 287 cells; B: n = 4 retinas, 150 cells). Data are mean ± SD. (C
and D) Responses to brief (35-ms) flashes of light. (Insets) Responses of single
cells in gray (C, n = 47 cells; D, n = 33 cells) and population average in black
with mean τoff. All traces were fit exponentially, and the time constants for
the peak decay reflecting MAG0460 dark relaxation are shown as scatter
plots and summarized in a box plot. (E–H) LiGluR responses to frequency-
modulated stimulation (50-ms flashes) (E, n = 77 cells; F, n = 67 cells; G, n =
70 cells; H, n = 65 cells). (Top) Raster plots showing indication of light flashes
in blue and single-unit spikes in black (500-ms bins). (Bottom) PSTHs showing
population averages of all single-cell responses to 4 Hz and 10 Hz of stim-
ulation in black, with a gray shadow indicating the standard error (SEM).
Fig. 4. LiGluR expression downstream in RGCs synchronizes responses, and
LiGluR expression upstream in ON-BCs diversifies responses from the rd1mouse
in vitro (light intensity for all recordings: 24.7 mW/cm2 or 5.6 × 1016 photons per
cm−2·s−1). MEA data from wt retina (A, E, and I), rd1 retina treated with LiGluR-
MAG0460 in RGCs (B, F, and J) or ON-BCs (C, G, and K), and rd10 retina treated
with LiGluR-MAG0460 in ON-BCs (D, H, and L) are shown. (A–D) Representative
raster plots of RGC responses to a 1-s flash of light (A, n = 17; B, n = 12; C, n =
15; D, n = 17 cells). (E–H) Representative traces from single units in response to
1-s light flashes (D, n = 16; E, n = 14; F, n = 28; G, n = 17 cells; 250-ms bins). The
blue bar indicates the light flash. The light responses are quantified by calcu-
lating the PI (normalized firing rate light-dark; E, n = 20; F, n = 17; G, n = 57; H,
n = 29 cells). Positive values indicate an increase in firing rate, and negative
values indicate a decrease in firing rate in response to light. (I–L) Correlation
matrices showing correlations between all light-sensitive single units. RGC
responses during the 1-s flash and 100 ms immediately before and after the
flash were used for the correlation. The color of the heat map indicates the
magnitude of the correlation value r, with warmer colors indicating higher
values (I, n = 72 cells; J, n = 111 cells; K, n = 82; L, n = 76 cells).














and after the flash were used to construct the correlation ma-
trices. Heat maps represent the correlation score, with warm
colors representing high correlation values. Using this unbiased
and inclusive analysis, we confirmed that LiGluR-MAG0460 in
RGCs leads to uniform responses across all cells (Fig. 4J and Fig.
S6 B and C), whereas LiGluR-MAG0460 in ON-BCs yielded
overall lower correlation in RGC output (Fig. 4K and Fig. S6 B
and C). The wt retinas with photoreceptor-driven activity showed
low levels of correlation (Fig. 4I and Fig. S6B) as expected due to
the functional diversity of RGCs. The ON-BC–LiGluR–MAG0460
correlation matrix showed a higher diversity of responses and
shared more similarity with wt retinas than with retinas that have
LiGluR-MAG0460 in RGCs. LiGluR-MAG0460 in ON-BCs of the
rd10 mouse retina, which undergoes slower retinal degeneration,
also showed higher levels of diversity or low levels of correlation
(Fig. 4 D, H, and L and Fig. S6B) similar to LiGluR-MAG0460
installed in ON-BCs of the rd1 mouse retina, indicating that the
effect we observed was specific to the different target cells and not
a function of retinal degeneration.
LiGluR Restores Innate and Learned Associative Light-Guided
Behavior. We next asked whether LiGluR-MAG0460 could restore
basic visually guided behavior. Mice naturally avoid brightly lit open
spaces (37). This preference is absent in adult rd1 mice that have
lost all rod and cone photoreceptors (14, 16). To test for restoration
of light avoidance, we placed wt mice and rd1 mice with LiGluR in
RGCs or ON-BCs in an open field test (Fig. 5A) and tested their
behavior before and after treatment with MAG0460. Mice were first
habituated to the testing environment, which consisted of an
open-topped plastic box with dark and light compartments
connected by a small opening (Fig. 5A), and then allowed to
explore the box for 5 min. The percentage of time spent in the
light compartment was recorded (16). Following intravitreal in-
jection of MAG0460, mice with LiGluR in RGCs (n = 18) or ON-
BCs (n = 13) showed a strong light avoidance, which was similar
to the light avoidance of wt mice (n = 4) (Fig. 5B).
After establishing that we can restore light avoidance behav-
ior, we asked how long the restoration of the light response
would last following a single intravitreal injection of MAG0460 as
the receptor protein on the cell surface turns over. Following a
single intravitreal injection of MAG0460 in rd1 mice expressing
LiGluR in RGCs, the light-induced firing of RGCs in isolated
retinas was found to decline with a time constant of ∼9 d (τ =
8.8 d) (Fig. 5C). The behavioral preference for the dark com-
partment declined over a similar time course following a single
intravitreal injection of MAG0460 (Fig. 5D).
Because LiGluR-MAG0460 targeted to either RGCs or ON-
BCs can restore the ability of blind mice to distinguish light from
dark, we wanted to test whether it would also enable animals to
distinguish temporal patterns of light and use this information in
the context of a learned behavior. Based on our finding that
LiGluR-MAG0460 can follow moderate frequencies of intensity
modulation (Fig. 3 E and F), we created two visual stimuli of
identical intensity, with the cue stimulus flashing at a rate of 2 Hz
and the decoy stimulus emitting light of constant intensity. These
visual stimuli were presented in a radial arm water maze that was
modified into a forced two-choice task (Fig. 5E). Mice were first
habituated to the maze and then trained to associate a specific
light cue with a hidden escape platform (38) for 8 d at 20 trials per
day. These conditions were chosen to maximize exposure of mice
to this task within the efficacy period of a single treatment with
MAG0460, as determined by the open field test (Fig. 5 C and D).
A correct trial was defined as a mouse finding the platform in
under 1 min without exploring the wrong arm of the maze first.
We used four groups of mice for this study: wt mice (positive
control), rd1 mice expressing LiGluR in RGCs or ON-BCs and
injected intravitreally 24 h prior to day 1 with MAG0460 (ex-
perimental), and rd1 mice that were sham-injected (negative
control). The wt mice (n = 6) performed well, improved gradu-
ally, and were able to learn the task (P < 0.016) within 8 d (Fig.
5F and Fig. S7A), in agreement with earlier studies (38). The
performance of sham-injected rd1 mice (n = 8) did not improve
(P = 0.815) over the 8-d experiment (Fig. 5F and Fig. S7B). In
contrast, rd1mice with LiGluR-MAG0460 in either RGCs (n = 9)
or ON-BCs (n = 6) learned to distinguish the temporally pat-
terned stimulus from the decoy stimulus (P < 0.0025 and P <
0.017, respectively) (Fig. 5F and Fig. S7 C and D). The light
intensities used for the light avoidance and water maze tasks
were 7 mW/cm2 or 1.6 × 1016 photons per cm−2·s−1 and 5 mW/
cm2 or 1.1 × 1016 photons per cm−2·s−1, respectively, which
correspond to outdoor light levels on a sunny day (approxima-
tion in Fig. S8).
Fig. 5. LiGluR expression restores innate and learned light-guided behavior
in rd1 mice in vivo. (A) Schematic showing the light/dark box for the open
field test. (B) Percentage of time spent in the dark compartment plotted
before (black) and after (gray) administration of MAG0460 for rd1 RGC-
LiGluR (n = 18), rd1 ON-BC–LiGluR (n = 13), and wt mice (n = 4). Data are
mean ± SEM. **P < 0.005, ***P < 0.0005; paired Student t test (light in-
tensity: 7 mW/cm2 or 1.6 × 1016 photons per cm−2·s−1). (C) Biological t1/2 of
intravitreally injected MAG0460. RGC-LiGluR–expressing rd1 mice were
injected with a single dose of MAG0460 in vivo 24 h before day 1. Sub-
sequently, on days 2–14, retinal explants were prepared and responses to 3-s
flashes were plotted. The decay of LiGluR-MAG0460–induced light responses
was fit with an exponential curve decay constant τ = 8.75 ± 0.79 d. (D) Ef-
ficacy of MAG over time in vivo. RGC-LiGluR–expressing rd1mice (n = 7) from
B were tested over the course of 10 d. The percentage of time spent in the
dark compartment is plotted for rd1 RGC-LiGluR mice before MAG0460 (n =
18) and for rd1 RGC-LiGluR mice after receiving a single intravitreal dose of
MAG0460 at day 2 (n = 18), day 4 (n = 7), day 6 (n = 7), day 8 (n = 7), and day
10 (n = 7). Data are mean ± SEM. *P < 0.01, ***P < 0.0001; multiple t tests
with Bonferroni correction. (E and F) Forced two-choice associative learning
task with a modified radial arm maze. (E) Schematic of the maze with
dimensions given in centimeters. (F) Performance of the four groups of mice
on day 1 (black) vs. day 8 (gray). Percentage of correct choices is plotted for
sham (PBS)-treated rd1 mice [−LigluR, −MAG0460 (n = 8); rd1 RGC-LiGluR +
MAG0460 (n = 9); rd1 ON-BC–LiGluR + MAG0460 (n = 6); and wt mice (n = 6)].
Data are mean ± SEM. *P < 0.05, **P < 0.005, paired Student t test (light
intensity at the divider 5 mW/cm2 or 1.1 × 1016 photons per cm−2·s−1).
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LiGluR in RGCs Restores the Retinal Light Responses in a Canine Model
of Retinal Blindness. Next, we wanted to confirm that the LiGluR-
MAG460 system could be virally delivered and drive functional
light responses in a larger animal model. To assess whether
LiGluR-MAG0460 is effective in a human-sized eye, we expanded
our study to the canine model, which provides both anatomical
and pathological similarities that are clinically relevant for testing
retinal therapies (39). The rod-cone dystrophy (rcd1) model has
a nonsense mutation in PDE6B, the same gene that is defective in
the rd1 and rd10 mice. We used an AAV2/2(4YF) vector in
combination with the ubiquitous cytomegalovirus CMV promoter
variant CAG to deliver the LiGluR transgene to RGCs (Fig. 6 A
and B). Intravitreal injection of AAV2/2(4YF)-CAG-LiGluR in
the area centralis, a region of high RGC density in the canine
retina (40), resulted in potent expression in RGCs by 8 wk post-
injection (Fig. 6 C and D).
MEA recordings were performed in three degenerated retinas
from two mutant rcd1 dogs that had been intravitreally injected
8–11 wk earlier with AAV2/2(4YF)-CAG-LiGluR. Stimulation
with high-intensity (75 mW/cm2 or 1.7 × 1017 photons per cm−2·s−1)
blue light in the absence of MAG0460 did not alter the baseline
RGC firing activity (Fig. 6E). However, following 20 min of in-
cubation in 100 μM MAG0460 and thorough washout, strong and
repeated periods of light-induced firing were seen that peaked
shortly after the onset of light (Fig. 6 F and G). To explore the
sensitivity of LiGluR-MAG0460 to photopic light levels typically
encountered within the brightly illuminated working/living envi-
ronment of humans, we performed MEA recordings in the rcd1
canine retina at different levels of blue light ranging from 6.8 to
0.43 mW/cm2 or 1.5 × 1016 photons per cm−2·s−1 to 9.7 × 1014
photons per cm−2·s−1, respectively. Light stimulations (1-s dura-
tion) induced RGC firing that was still detectable at the lowest
(0.43 mW/cm2 or 9.7 × 1014 photons per cm−2·s−1) irradiance and
increased with higher intensities (Fig. 6H). Responses to all five
intensities had a transient component and a sustained component,
and showed similar kinetics with rapid inactivation time from
steady-state to baseline levels (40 ms) upon offset of light (Fig. 6I).
To develop future psychophysical tests to be used in dogs and
human patients for the assessment of visual function recovery
after intervention with LiGluR-MAG0460, we examined the re-
sponse of the retina to a combination of higher frequency (4 Hz),
shorter duration (50 ms), and low light intensity (0.85 mW/cm2
or 1.9 × 1015 photons per cm−2·s−1) stimulations. Whereas peak
firing rate was reduced and a slight delay was introduced in
comparison to responses achieved with longer stimulations at
higher intensities, a distinct light-induced ON response of RGCs
that peaked at the end of the 50-ms stimulation period could
be detected (Fig. 6J). Rapid relaxation of the photoswitch (τoff ≈
28 ms) occurred upon returning to darkness (Fig. 6J, Inset).
Discussion
In this study, we show the translational potential of the LiGluR-
MAG0460 system for retinal gene therapy to cure human blind-
ness. In a mouse model of the human retinal degenerative dis-
ease RP, we observed restoration of a useful retinal output in
response to light when LiGluR was expressed either in the most
upstream or the most downstream cell types that survive after
photoreceptor degeneration. In vivo, these retinal responses re-
stored an innate light-guided behavior and enabled light-associated
learning based on cues with distinct temporal patterns.
Earlier work validated the use of LiGluR in conjunction with
a first-generation MAG0 photoswitch in RGCs for vision resto-
ration (23). However, the therapeutic utility of the first-generation
MAG0 was limited by two properties. First, the spectral
sensitivity of the original MAG0 chromophore was outside of the
visible range, peaking in the UV light at 380 nm (41), which
penetrates the lens poorly and is damaging to corneal, lens ep-
ithelial, and retinal cells. Second, LiGluR-MAG0 was bistable,
requiring a second longer wavelength pulse of light to reset the
system after each activating event (19, 41), which would neces-
sitate additional hardware for potential clinical applications.
We solved these problems with our photoswitch, MAG0460,
Fig. 6. LiGluR expression in RGCs restores light responses in the rcd1 canine
retina in vitro. (A) Viral DNA expression cassette. LiGluR expression is driven by
CAG promoter. (B) Schematic of degenerated canine retina with targeted
RGCs in green. (C and D) Confocal images of LiGluR expression in canine retina
8 wk after intravitreal injection of AAV2/2 (4YF)-CAG-LiGluR. (Scale bars:
20 μm.) (C) Whole-mount view of LiGluR expression in RGCs of rcd1 canine
retina. (D) Cross-section of LiGluR expression in RGCs of wt canine retina. (E–J)
MEA recordings (light intensity: 75 mW/cm2 or 1.7 × 1017 photons per cm−2·s−1
if not specified otherwise) of rcd1 mutant canine retinas. MEA recording from
an rcd1mutant dog expressing LiGluR (n = 160 cells) before (E) and after (F) in
vitro application of MAG0460. (G) Comparison of the firing rate averaged over
a 3-s flash of light (500-ms bins) on three LiGluR-expressing rcd1 retinas in the
dark vs. light (dashed line, 6.8 mW/cm2 or 1.5 × 1016 photons per cm−2·s−1; solid
lines, 75 mW/cm2 1.7 × 1017 photons per cm−2·s−1) before (n = 2 retinas, 193
cells, gray) and after (n = 3 retinas, 291 cells, green) in vitro application of
MAG0460, with population means (black and blue, respectively). (H) Dynamic
range of rcd1 retina treated with LiGluR-MAG0460 at lower light conditions
(n = 80 ± 5 cells). Data are mean ± 2 SEM binned at 100 ms. (I) Averaged
normalized response to stimulation with five light intensities (0.43, 0.85, 1.7,
3.4, and 6.8 mW/cm2 or 9.7 × 1014, 1.9 × 1015, 3.8 × 1015, 7.7 × 1015, and 1.5 ×
1016 photons per cm−2·s−1, respectively) shown in H with individual responses
shown in gray, average response over all intensities shown in black, and the
response inactivation time shown in blue (ΔToff). (J) MEA recording from an
rcd1 retina treated with LiGluR and MAG0460 (n = 77 cells) stimulated at low
intensity (0.85 mW/cm2 or 1.9 × 1015 photons per cm−2·s−1) at 4 Hz (50-ms
duration, 200-ms ISI) binned at 10 ms. (Inset) Average of 400 individual
responses (5-ms bins) with a single exponential fit (blue trace) and time constant
(τoff ∼ 28 ms) for MAG0460 relaxation from peak response to baseline.














which is activated by blue light similar to blue cone photoreceptors,
responds well to broad-spectrum visible light, and rapidly and
spontaneously turns off in the dark (24). LiGluR-MAG0460
responds dynamically to incremental changes in light intensity
and supports reliable retinal output with intensity modulations at
moderate frequencies of 4–10 Hz.
We compared two gene therapy target cell types, RGCs and
ON-BCs, for LiGluR-MAG0460 expression in the degenerating
mouse retina. RGCs are well-suited therapy targets for late-stage
disease because they have been shown to stay morphologically
intact (4) with minimal remodeling following photoreceptor de-
generation compared with the other retinal cells (27). Furthermore,
RGCs are easily targeted due to their proximity to the vitreous,
enabling strong, uniform, and widespread expression after intra-
vitreal injection of AAV vectors. ON-BCs, however, are prom-
ising therapeutic targets for early-stage disease because they are
located upstream in the retinal circuit and provide an opportu-
nity to preserve aspects of retinal processing (32, 33).
Robust light responses were restored to the RGCs of retinas
isolated from blind mice when LiGluR-MAG0460 was installed in
either the RGCs themselves or in ON-BCs. The sensitivity,
ability to follow frequency-modulated light, and on/off kinetics in
response to full-field illumination were similar for the two cell
types. The similarity is striking considering that expression was
much sparser after viral delivery to the ON-BCs (compare Fig.
S2 A and B). Comparable sensitivity at lower expression suggests
that the signal amplification due to convergence from BCs to
RGCs (42) makes the ON-BC population particularly effective
for vision restoration and highlights the value of further im-
provement for gene delivery to these cells.
There was an important distinction between the properties of
the restored retinal output activity when LiGluR-MAG0460 was
installed in the two cell types. In rd1 mouse ON-BCs, LiGluR-
MAG0460 drove RGC activity that was temporally diverse and
excited a subset of RGCs, whereas other RGCs were inhibited by
light. In contrast, LiGluR-MAG0460 in rd1 mouse RGCs led to
uniform light responses, as one would expect from direct exci-
tation of the RGCs. The signal diversity that emerges from the
retinal circuit when LiGluR-MAG0460 is installed in ON-BCs
could be beneficial for restoring critical aspects of visual pro-
cessing, such as contrast and edge detection (43). Single-unit
RGC responses from ON-BC LiGluR-MAG0460 in both rd1 and
rd10 resembled the RGC responses seen in wt retina more
closely than RGC LiGluR-MAG0460. ON-BCs might therefore
be the target of choice in early stages of retinal degeneration,
before substantial synaptic remodeling has occurred (27). In late
stages of retinal degeneration with severe circuit degeneration, it
may be preferable to target the least affected cells, the RGCs, to
generate a strong and synchronized output signal.
We tested the function of LiGluR-MAG0460 in vivo and found
that the restored retinal activity supported normal light-avoidance
behavior in blind treated mice using the open field test.
Having established that our treatment supported light-guided
behavior, we next asked whether the LiGluR-MAG0460 system
would enable blind mice to learn to distinguish different visual
cues in the context of a forced two-choice variant of the Morris
water maze task. In this experiment, mice were challenged to
associate a temporally patterned cue stimulus from a non-
patterned intensity-matched decoy stimulus. The wt mice were
able to learn to associate the patterned stimulus with the reward,
whereas untreated rd1 mice were not and did not improve their
performance over the 8 d of the experiment. Rd1 mice treated
with LiGluR-MAG0460 in either the RGCs or ON-BCs learned to
perform as well as wt animals, indicating that the LiGluR-
MAG0460 system operates as more than just a mere light meter
and can inform mice about qualitative aspects of the visual world.
In this study, we did not attempt to record visually evoked
potentials, record electroretinograms, or test for a pupillary light
reflex as we did for our previous study (23). Instead, we focused
our efforts on learned associations and demonstrated the ability of
mice to recognize temporal patterns in the water maze task. We
have not yet tested these mice for spatial pattern recognition or
temporal and spatial pattern resolution.
Our results in the mouse model encouraged us to test if our
treatment could be translated to a larger animal model. Specif-
ically, we set out to test virus-mediated expression of the LiGluR
receptor and the ability of LiGluR-MAG0460 to drive light re-
sponses in retinal explants. To this end, we selected the rcd1 dog,
which, like the rd1 mouse, has severe and early-onset rod and cone
degeneration (44, 45). We developed a virus for canine RGC
transduction and tested patches of retina collected from the area
centralis region for LiGluR-MAG0460–induced light responses in
vitro. LiGluR-MAG0460 in the RGCs rendered the blind dog retina
light-sensitive, with characteristics closely matching the character-
istics observed in the rd1mouse. Our results show that the LiGluR-
MAG0460 system in excised rcd1 canine retina responds well to
stimulation at a light intensity found under natural environmental
conditions [0.43 mW/cm2, which approximates outdoor conditions
(Fig. S8)] and moderate frequencies (up to 4 Hz). These findings
pave the way for future efforts in the canine model to determine
toxicity and a therapeutic index for the MAG0460 photoswitch and
to perform behavioral testing in advanced retinal degeneration.
A recent study restored the ability to distinguish light from dark
using just a chemical photoswitch that acts on native ion channels,
including those native ion channels that are up-regulated in the
RGCs of the degenerating mouse retina (17). Compared with this
optochemical therapy, which has advantages of not requiring gene
transfer and being more sensitive to light (comparison of threshold
light intensities in Fig. S8), our two-component optochemical-ge-
netic therapy has the advantage of designed cell-type targeting. In
addition, covalent attachment of the chromophore allows us to
work at lower concentrations of the photoswitch chemical, a factor
that, along with targetability, could provide a better safety profile.
In both the optochemical and optochemical-genetic therapy
approaches, a bolus supply of the photochemical restores light-
guided behavior temporarily for a period of days. In the opto-
chemical case, the limited efficacy is presumably due to washout of
the molecule, whereas in our optochemical-genetic case, it is most
likely due to turnover of the photoswitch-conjugated receptor. As
a result, both of these approaches would benefit from sustained-
release drug delivery technology.
An alternative purely optogenetic approach has proven suc-
cessful for restoration of light responses in retinal cells, light
responses in visual cortex, light aversion, and learned association
tasks using unpatterned light. For this approach, microbial opsins
are expressed in specific cell types of the degenerated retina from
cone cell bodies that have lost their outer segment to ON-BCs and
RGCs (10, 13, 14, 16). The simplicity of this genetic therapy is
appealing, as is the ability of the microbial opsins to use the ret-
ina’s supply of 11-cis-retinal as the natural photoswitch. One
concern about this approach is the possibility of an immune re-
sponse to the foreign protein, which, in the worst case scenario,
could spread into the brain via the optic nerve. In addition, once
expressed, these opsins cannot be turned off in case of an adverse
reaction. Our success with a mammalian light-gated protein that is
identical in amino acid sequence to the native protein, except for
a single amino acid substitution that creates the photoswitch an-
choring site, reduces the risk of immune reaction. In addition, the
dependence on chronic delivery of the synthetic photoswitch
should make it possible to discontinue treatment in case of an
adverse reaction as well as to replace the synthetic photoswitch
with improved photoswitches as they become available.
In summary, we have shown that the LiGluR-MAG0460 system
operates successfully in either ON-BCs, at the upstream end of
the degenerating retina, or at the output end of the retina, in
RGCs, to restore retinal light responses and enable innate and
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learned light-guided behavior in blind mice. Installation in the
ON-BCs, which is probably most appropriate for early-stage de-
generation, provides more diverse retinal output characteristics
and may support higher quality vision, a notion that will require
future testing. Importantly, the system is equally effective in the
rcd1 dog in vitro, paving the way for extensive testing of high-
resolution vision in a preclinical setting and for clinical de-
velopment. Our approach should allow for the use of a receptor
protein based on the patient’s own receptor, reducing the chance
of an immune response. Because the functional properties of the
restored light response depend on the externally provided pho-
toswitch, it can be tailored to the patient and improved as new
photoswitches become available; equally importantly, the func-
tion of the system can be aborted in case of adverse effects by
curtailing photoswitch delivery.
Methods
Animals. All mouse experiments were performed with approval of the Uni-
versity of California Animal Care and Use Committee. The wt mice (C57BL/6J)
and rd1mice (C3H) were purchased from the Jackson Laboratory and housed
on a 12-h light/dark cycle with food and water ad libitum. The age of the
mice ranged from p30–p60 for rAAV injections and from p90–p160 for in vivo
and in vitro experiments.
All experiments on dogs were approved by the Institutional Animal Care
and Use Committee of the University of Pennsylvania and were carried out in
strict accordance with the recommendations in the Guide for the Care and
Use of Laboratory Animals of the NIH (46) and with the US Department of
Agriculture’s Animal Welfare Act and Animal Welfare Regulations, and
complied with the Association for Research in Vision and Ophthalmology
Statement for the Use of Animals in Ophthalmic and Vision Research. Three
rcd1 dogs (PDE6B mutation) (47) with late-stage retinal degeneration (0.4,
1.8, and 3.7 y of age) and one normal dog (2.4 y of age) were used to assess
viral vector tropism and for MEA experiments (details are provided below).
Injection of rAAV and MAG Photoswitch. AAVs were produced via standard
methods (48). We selected rAAV2/2 carrying the LiGluR transgene under the
control of the hsyn-1 promoter for RGC targeting. For ON-BC targeting, we
selected rAAV2/2(4YF) carrying the LiGluR transgene under the control of
the 4x repeat of the mGluR6 promoter (4xgrm6), a kind gift from Botond
Roska (Friedrich Miescher Institute, Basel) and Connie Cepko (Harvard
Medical School, Boston). The titer of AAV was determined via quantitative
PCR relative to the inverted terminal repeat domains standard. Titers for
these viruses ranged between 1 × 1013 viral genomes (vg)/mL and 1 × 1014
vg/mL. Mice were anesthetized with i.p. ketamine (72 mg/kg) and xylazine
(64 mg/kg). Eyes were additionally anesthetized with proparacaine (0.5%),
and pupils were dilated with phenylephrine (2.5%) and tropicamide (1%).
Injections consisted of a two-step process. First, an incision was made pos-
terior of the ora serrata using a sharp 30-gauge needle. Then, a 2-μL volume
of MAG0460 photoswitch diluted in PBS/DMSO or an estimated amount of 5 ×
1011 viral genomes of AAV diluted in PBS (with 1% phenol red as a contrast
agent) was injected intravitreally for rAAV2/2-hsyn-LiGluR or subretinally for
rAAV2/2(4YF)-4xgrm6-LiGluR using a blunt 32-gauge Hamilton syringe. Efflux
was minimized by keeping the Hamilton needle tip in the eye for >60 s.
Intravitreal injections in dogs were performed under general gas (iso-
fluorane) anesthesia. A 150-μL volume of rAAV2/2 (4YF) carrying the GFP
reporter gene under the control of the ubiquitous CAG promoter was de-
livered intravitreally (preretinally) to the superior/tapetal fundus region of
a 20-wk-old mutant rcd1 dog using a 39-gauge polyimide cannula (RetinaJet;
SurModics, Inc.). The right eye was injected with a viral titer of 1.46 × 1011 vg/mL,
whereas the contralateral (left) eye received a 10-fold higher viral titer
(1.46 × 1012 vg/mL). At 12 wk postinjection, expression of GFP was assessed
by noninvasive retinal imaging using a scanning confocal laser ophthalmoscope
(HRA/OCT; Heidelberg Engineering) set on the autofluorescencemode. Following
euthanasia, the eyes were processed for immunohistochemistry as stated below
and localization of GFP expression to retinal cell populations was examined.
Subsequently, an AAV2/2(4YF)-CAG-LiGluR viral construct was produced and
injected preretinally to the area centralis region of one normal and the two rcd1
mutant dogs. The rAAVwas diluted in balanced salt solution (Alcon Laboratories),
and 200 μL of two viral titers (1.46 × 1011 vg/mL and 5 × 1011 vg/mL) was injected.
MAG Preparation. A stock solution of 100 mM MAG0460 (L-diastereomer) (24)
in 100% pharmaceutical grade DMSO (Cryoserv; Bioniche Pharma) was di-
luted 1:100 in sterile PBS for a final working solution of 1 mM in 1% DMSO.
Working solutions were prepared immediately before administration and
were used within 20 min to avoid hydrolysis of the maleimide group. In vitro
conjugation of MAG0460 on retinal explants for electrophysiological recordings
was performed in a volume of 200 μL at a concentration of 100 μM MAG0460
(in PBS with >1% DMSO). For in vivo experiments and the MAG efficacy ex-
periment (Fig. 5), a 2-μL volume of 1 mM MAG0460 solution (in PBS with 1%
DMSO) was injected into eyes that had been treated with AAV >6 wk earlier.
In dogs, 1 mL of 100 μM MAG0460 (in Ringer’s solution) was applied to the
retinal explants for MEA recordings.
Tissue Preparation and Immunohistochemistry. Mice were killed >4 wk (for
RGC-LiGluR) or >6 wk (for ON-BC–LiGluR) post-AAV injection, and the eyes
were enucleated and fixed in 4% paraformaldehyde (Ted Pella) for 1 h.
Whole-mount retinas were prepared by making a complete circular incision
around the ora serrata using scissors, removing the cornea while leaving the
lens attached, gently tearing the eyecup apart using two forceps, and finally
removing the lens. Radial cuts were made to flatten the retina, resulting in
the typical cloverleaf shape. For retinal sections, whole mounts were em-
bedded in agarose (Sigma) and sectioned transverse using a vibratome (Leica
Microsystems) at medium speed, maximum vibration, and 150-μm thickness.
Whole mounts and vibratome sections were incubated in blocking buffer
[10% normal goat serum, 1% BSA, 0.5% Triton X-100 in PBS (pH 7.4)] for 2 h
at room temperature (RT). Monoclonal antibody against GluK2/K3 (Milli-
pore) was applied at a 1:500 dilution in blocking buffer overnight at 4 °C.
Secondary anti-rabbit Alexa 488 or Alexa 594 antibody (Invitrogen) was ap-
plied at a 1:1,000 dilution in blocking buffer for 2 h at RT. Tissue was washed
three times for 10 min with PBS and mounted on slides using Vectashield
(Vector Laboratories) mounting mediumwith DAPI to stain cell nuclei. Whole
mounts and sections were imaged via confocal microscopy (LSM7; Carl Zeiss).
To identify off-target cell expression outside of the expected layer, we pre-
pared a total of 44 vibratome sections from four treated retinas from three
mice [previously injected with AAV2/2-hsyn-LiGluR or AAV2/2(4YF)-4xgrm6-
LiGluR] and counted the number of labeled cell bodies outside of the RGC
layer or the IPL, respectively. In dogs, ocular tissues were collected following
i.v. injection of a euthanasia solution (Euthasol; Virbac). Retinal tissues used for
immunohistochemistry on retinal cryosections or whole mounts were pro-
cessed as previously reported (40) and examined by confocal microscopy
(Leica TCS SP5; Leica Microsystems).
HEK Cell Recordings. HEK 293T cells were transfected with an LiGluR ex-
pression vector [pcDNA-GluK2(Q) L439C] using Lipofectamine 2000 (Invi-
trogen) and YFP as a transfection marker (24, 49) Cells were labeled after
expression for 24–48 h at 37 °C. Cells were washed with external solution,
incubated for 2 min with 0.3 mg/mL Con A to block ligand-induced de-
sensitization, and labeled with ∼25 μMMAG0460 or regular MAG0 (19) for 40
min in extracellular solution at RT in the dark. After labeling, any unreacted
MAG was removed by thorough washing with external solution. Whole-cell
HEK cell recordings were performed in voltage-clamp configuration, typi-
cally at −75 mV, on an inverted microscope (Olympus IX) using an Axopatch
200B head stage/amplifier (Molecular Devices) at 22–24 °C. Patch pipettes
were pulled from borosilicate glass to give 3–7 MΩ resistance when filled
with internal solution [135 mM K-gluconate, 10 mM NaCl, 10 mM Hepes,
2 mM MgCl2, 2 mM MgATP, 1 mM EGTA (pH 7.4)]. The extracellular solution
was 138 mM NaCl, 1.5 mM KCl, 1.2 mMMgCl2, 2.5 mM CaCl2, 10 mM glucose,
and 10 mM Hepes (pH 7.3). Photoswitching (Fig. 1 C and D and Fig. S1 A and
B) was achieved with a xenon-lamp light source (DG4; Sutter Instruments) in
combination with excitation filters [445/20 nm, 379/34 nm, and 500/24 nm
(“center”/“full width > 90%”) and a set of neural density filters (XND;
Omega Optical). The DG4 light source was coupled via liquid light guide to
the back-port of the microscope to give homogeneous illumination through
a LUCPlanFLN (Olympus) 0.60-N.A., 22-field number objective with a mag-
nification of 40×, yielding an irradiance up to 500 mW/cm2 (445 nm) at the
sample stage. Dynamic intensity modulation (Fig. S1 C and D) was performed
using a collimated light-emitting diode (LED) light source (470 nm; Thorlabs)
coupled to the back-port of the microscope. The intensity was modulated
with an analog signal from a Digidata A/D-converter (Molecular Devices).
MEA Recordings. MEA recordings were performed on wt (C57BL/6J) mice,
untreated control mice, and treated rd1 mice (fast retinal degeneration
model), as well as rd10 mice (slow degeneration model). Control mice and
wt mice were used at an age >p90. Experimental mice were used 6–10 wk
following AAV injection. Rd10 mice were used at an age >6 mo. For
recordings, the retina was placed ganglion cell side down (50) in the re-
cording chamber (pMEA 100/30iR-Tpr; Multi Channel Systems) of a 60-
channel MEA system with a constant vacuum pump (perforated MEA1060














system with CVP; Multi Channel Systems). A custom-made dialysis membrane
weight was placed on the retina, adding positive pressure from above.
Additionally, a vacuum was applied to the retina using the constant vacuum
pump, adding negative pressure and improving electrode-to-tissue contact
and the signal-to-noise ratio. During recording, constant perfusion of oxy-
genated Ames media (34 °C) was provided to the recording chamber. For
rd10 mouse retina, we supplied LAP-4 (Sigma), a group III metabotropic
glutamate receptor agonist, to block any residual photoreceptor-mediated
response. Comparative analysis of responses before and after drug admin-
istration was used to ensure complete blockade of photoreceptor activity at
a working concentration of 20 μM. Recordings lasted between 1 and 3 h.
Illumination was provided by two different light sources that were both
coupled to an objective with a magnification of 4×. Light intensities were
measured with a handheld power meter (Thorlabs, Inc.). A 300-W mercury
arc lamp (DG-4; Sutter Instruments) with a blue bandpass filter (445/50 nm;
Thorlabs, Inc.) was used for initial recordings in Fig. 2 and Fig. S2. For later
recordings, an LED light source (470 nm, 24.7 mW/cm2 or 6.3 × 1016 photons
per cm−2·s−1; Thorlabs, Inc.) with a collimator lens (Thorlabs, Inc.) was used
for high-frequency stimulation (Fig. 3 and Fig. S5) and for all MEA recordings
in Fig. 4. Data were sampled at 25 kHz filtered between 300 and 2,000 Hz
and recorded using MCS rack software (Multi Channel Systems) for offline
analysis. Voltage traces were converted to spike trains offline by collecting
responses using the methods described below. Spikes recorded at one
electrode were sorted into single units, which we defined as “cells,” via
principal components analysis using Offline Sorter (Plexon). Single-unit spike
clusters were exported to MATLAB (MathWorks) and were analyzed and
graphed with custom software. For extracting firing rates in the dark, we
averaged all bins over 3 s preceding the flash to minimize fluctuations. To
extract firing rates in the light, the maximum response was taken, typically
the first two bins following the flash depending on bin size (bins ranged
from 20–500 ms). A cell was defined as a “responder” if the PI [(firing rate
light − firing rate dark)/(firing rate light + firing rate dark)] satisfied the
condition PI > 0.1 or PI < −0.1. All cells from one retina or all retinas per
condition were plotted for analysis unless otherwise noted (Fig. 4 A–D
showing representative traces and Fig. S5 showing “strong responders”). Two
different approaches were implemented to set the threshold for spikes: (i)
For plots showing cell-to-cell or retina-to-retina variability (Fig. 3 C–H, Figs. S3
and S4, and Table S1), the baseline for each cell was set at a threshold just
above electrical noise to include all possible spikes and show the full picture,
and (ii) for plots that show different retinas from different experiments
combined, the baseline for each retina was centered at a firing rate of 10–12
Hz in the dark to allow all retinas to be plotted on a similar axis (Fig. 2 K–N
and Fig. 3 A and B). Correlation matrices (Fig. 4) were constructed in MATLAB
with custom software. Peristimulus time histograms of every cell were cor-
related with one another. The firing rates during the 1-s flash and 100 ms
preceding the flash and 100 ms after the flash were used to compute the
correlation matrices. Correlation values ranged between 1 and 0. A heat map
was used to represent the correlation value of each data point in the matrix,
with warmer colors indicating higher correlation values.
For MEA studies in dogs, a 5-mm circular patch of neuroretina centered on
the area centralis was collected with a biopsy punch. A similar MEA protocol
as described above was followed in one rcd1 mutant dog (both retinas). The
preparation and recording of the second rcd1 dog retina differed slightly
from the method described above. Following transfer into an MEA chamber
(60-channel 200/30iR ITO array; ALA Scientific Instruments, Inc.), the retina
was centered on the array ganglion cell side down and covered with a piece
of dialysis membrane (Biotech RC Dialysis Tubing Trial Kit 20Kd Mwco; VWR)
that was presoaked in Ringer’s solution (119 mM NaCl, 2.5 mM KCl, 1 mM
KH2PO4, 1.3 mMMgCl2, 2.5 mM CaCl2, 26.2 mM NaHCO3, 20 mM D-glucose in
ddH20). A flat platinum ring (1-cm ring diameter, 1.0-mm wire diameter,
99.997%; VWR) was placed on top of the membrane to increase contact
between the retina and the MEA. Oxygenated Ringer’s solution equilibrated
with 95% O2/5% CO2 was added to the chamber. The chamber was then
transferred to the stage of an inverted microscope (Olympus IX51) and
locked in place following installation of an MEA amplifier (MEA1060-Inv;
Multi Channel Systems). The retina was first perfused with oxygenated
Ringer’s solution (rate of ∼3 mL/min) at RT for about 5 min, and a heating
system was then turned on to maintain the solution in the chamber in the
range of 35–37 °C. Recordings of RGC firing activity were done before and
after a 20-min incubation of the retina in the photoswitch solution. Data
were digitized at 10 kHz and stored on the computer hard drive using NI PCI-
6071E DAQ board and custom software developed in LabView (National
Instruments). For light stimulation, a 450-nm or 470-nm blue LED driven by
a custom-designed circuit under the control of custom software developed
in MATLAB was used. Light intensity was controlled by modifying the LED
duty cycle or by using neutral density filters. The retina was stimulated from
below the stage using an optical port and the 4× objective of the inverted
microscope. Light intensities and stimulation timing accuracy were measured
with a calibrated photodiode (OSI Optoelectronics). Light irradiances on the
sample plane ranged from 0.43 to 75 mW/cm2. A short pulse at the begin-
ning of each stimulation series was used to trigger data acquisition, and the
duration and timing of light stimulation events were recorded alongside
regular data on one of the unused channels. A custom MATLAB code was
used to retrieve, inspect, and convert the data into the 16-bit binary format
compatible with Plexon Offline Sorter (Plexon, Inc.). In the Plexon Offline
Sorter, data were high-pass–filtered at 200 Hz, and spikes were detected
using a 4 SD threshold and separated into signals from individual cells using
principal component analysis. The spikes with an interspike interval of less
than 1 ms were deleted. Spike sorting results were exported from Plexon
back into MATLAB for further analysis (generation of raster plots, calcula-
tion of firing rates, and kinetics analysis).
Open Field Test. The open field test was performed as described previously (16)
with minor modifications (Fig. 5A). Briefly, a plastic tub (dimensions: length =
60 cm, width = 40 cm, height = 30 cm) was separated into a light compart-
ment (length = 25 cm, width = 40 cm, height = 30 cm) with white walls and
a dark compartment (length = 35 cm, width = 40 cm, height = 30 cm) with
black walls. The light compartment was illuminated by a custom LED array (5 ×
6 LEDs, 447.5-nm Rebel LED; Luxeon Star LEDs) centered over the compart-
ment. The light intensity (7 mW/cm2 or 1.6 × 1016 photons per cm−2·s−1 at floor
level) was homogeneously distributed throughout the floor. The mice were
able to move around the box through a small opening (height = 5 cm, width =
10 cm) connecting the two compartments. Mice were brought into the testing
room in their home cages, transferred into the testing box, and allowed to
habituate to the new environment with their littermates for 45 min. Mice
were placed back in their home cage and then tested individually. Mice were
placed in the light compartment and were given a maximum of 3 min to
discover that there is a second compartment. A 5-min trial began when they
crossed into the dark compartment, and time spent in the light was recorded.
Mice that crossed the opening only once and stayed in the dark com-
partment for entire time were disqualified. Unlike wt mice, we noticed that
untreated rd1 mice showed signs of fear (i.e., hiding in corners, freezing
even in open spaces) in the new environment and did not move readily. We
reasoned that this fear would mask any light aversion effect, so we ha-
bituated the untreated rd1 mice in the dark until they moved readily
between compartments before testing. Mice injected >6 wk earlier with
AAV2/2-hsyn-LiGluR or AAV2/2(4YF)-4xgrm6-LiGluR were injected intra-
vitreally with MAG0460 and tested 2, 4, 6, 8, and 10 d later at a light intensity of
7 mW/cm2. Permanent records were made using a video camera (GoPro Hero3).
Forced Two-Choice Water Maze Task. The water maze task was performed
using the protocol described by Wong and Brown (38) with minor mod-
ifications. A radial arm maze was modified into a forced two-choice task by
blocking two of the five arms of the maze (Fig. 5E) and adding a divider
(dimensions: 25 cm × 25 cm) to separate the two potential “escape arms.”
Two custom-built LED arrays (5 × 6 LEDs, 447.5-nm Rebel LED) were placed
at the end of each escape arm. The light intensities at the release site
(2 mW/cm2 or 4.4 × 1015 photons per cm−2·s−1) and at the divider (5 mW/cm2 or
1.1 × 1016 photons per cm−2·s−1) were measured at the water level using
a handheld power meter (Thorlabs, Inc.). The LED array that cued the escape
platform was triggered with square pulses to flash at 2 Hz using a stimulus
generator (Stanford Research Systems).
The room was kept dark for the entire time of the experiment. Permanent
records were made using a videocamera (GoPro Hero3) positioned in the center
above themaze. On the day before the start of an 8-d trial, micewere habituated
to the maze. Mice were placed onto the platform for 1 min. They were then
released at increasing distances from the platform, and theywere finally released
from the chute for 10 trials. The same was repeated with the platform on the
opposite side. Additionally, eachdaybefore the experiment,mice received a short
habituation. They were placed onto the platform for 1 min on both sides and
returned to the cages. For each trial,micewere removed from their cage, placed
in a glass beaker (6-cm diameter), and then slowly (10–60 s) lowered into the
water at the arm opposite of the divider. Eachmouse was given a maximum of
60 s to find the platform. Trials in which mice found the hidden platform
without entering the alternative arm first were counted as correct trials. Trials
in which mice explored the alternative arm first or took longer than 60 s to
find the platform were counted as failed trials. After the trial, mice were dried
and placed into a warm chamber with a space heater and allowed to rest for
at least 3 min before the next trial. All mice performed 10 trials per session
with two sessions a day, with a total of 20 trials per mouse per day for 8
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consecutive days. The platform and the flashing LED were moved between
trials according to the following pattern: LRRLRLLRLR and RLLRLRRLRL on
alternating days. Mice that received a MAG0460 or sham (PBS) injection
were allowed to rest for >24 h afterward to avoid masking effects
from anesthesia.
Statistical Analysis. The Student’s’ t test was used for statistical analysis of
in vivo mouse physiology. Paired t tests were used for comparisons within
the same group of mice before and after MAG0460 treatment (Fig. 5 C and F
and Fig. S7). Multiple t tests were corrected for type I errors using the
Bonferroni correction.
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